Home > News > BePharBel Manufacturing continues its expansion in Belgium with the acquisition of Erfa Pharm pharmaceutical activities and related assets

News

06 March 2014

BePharBel Manufacturing continues its expansion in Belgium with the acquisition of Erfa Pharm pharmaceutical activities and related assets



BePharBel Manufacturing has announced the acquisition on 1st March of the pharmaceutical activities and related assets of the pharmaceutical company Erfa Pharm.

This strategic acquisition will flesh out the BePharBel Manufacturing product portfolio with high‐profile drugs such as Aureomycin®, Neobacitracine®, Codethyline®, Hydrocortisone®, and Delphi®. This operation will complement BePharBel Manufacturing’s existing production facilities with a view to meeting the development and manufacturing requirements of today’s market.

Click here to view the press release.